Post-Coronavirus Disease 2019 Effects in an Active University Population: A Within-Campus Cross-Sectional Study at a Major Educational Institution
Objective: To evaluate the associations among post-coronavirus disease 2019 (COVID-19) prevalence; risk factors and comorbidities have not been firmly established within a university outpatient population. Patients and Methods: Records from 881 COVID-19 outpatient patients (504 females [57.9%] and 3...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Mayo Clinic Proceedings: Innovations, Quality & Outcomes |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2542454824000651 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850176001865154560 |
|---|---|
| author | Marcelo Hernández-Mora, MD René Arredondo-Hernández, PhD Carmen A. Castañeda-Camacho, MD Pamela X. Cervantes-Gutierrez, MD Gonzalo Castillo-Rojas, PhD Samuel Ponce de León, MD Yolanda López-Vidal, PhD |
| author_facet | Marcelo Hernández-Mora, MD René Arredondo-Hernández, PhD Carmen A. Castañeda-Camacho, MD Pamela X. Cervantes-Gutierrez, MD Gonzalo Castillo-Rojas, PhD Samuel Ponce de León, MD Yolanda López-Vidal, PhD |
| author_sort | Marcelo Hernández-Mora, MD |
| collection | DOAJ |
| description | Objective: To evaluate the associations among post-coronavirus disease 2019 (COVID-19) prevalence; risk factors and comorbidities have not been firmly established within a university outpatient population. Patients and Methods: Records from 881 COVID-19 outpatient patients (504 females [57.9%] and 366 males [42.07%]), most of whom were between 30 and 40 years of age (mean=37.3 years old; 95% CI, 36.5-38.2), with initial infection data from February 2020 to August 2022 were reviewed once, whereas the survey took place during 2 different moments during the pandemic. The first period (April 20, 2021, to June 21, 2021) yielded 279 responses, whereas in the second period (June 23, 2021, to October 4, 2021), 602 responses were recorded. The instrument used contained 20 questions across 3 main domains: general information, data related to infection and adverse effects, and service satisfaction experience. Results: All the patients were positive for immunoglobulin G antibodies against nucleocapsid by the third week. Post-COVID-19 symptoms arose at least 2 weeks after recovery from the initial illness; 654 individuals reported at least one symptom after the acute COVID-19 period, for a post-COVID-19 prevalence of 74.96%. The most frequent symptoms were fatigue (84%), headache (71%), and difficulty concentrating (71%). More than 60% of participants reported at least one comorbidity, among which the most common ones were obesity (35.9%), smoking (17.5%), and hypertension (12.2%). Conclusion: In this study, we assessed post-COVID-19 prevalence among outpatients and found that comorbidities were strongly related to consequences impacting quality of life and mental health burden. |
| format | Article |
| id | doaj-art-ffde608568ac480f9e2912827d6495e0 |
| institution | OA Journals |
| issn | 2542-4548 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Mayo Clinic Proceedings: Innovations, Quality & Outcomes |
| spelling | doaj-art-ffde608568ac480f9e2912827d6495e02025-08-20T02:19:21ZengElsevierMayo Clinic Proceedings: Innovations, Quality & Outcomes2542-45482024-12-018652152910.1016/j.mayocpiqo.2024.09.004Post-Coronavirus Disease 2019 Effects in an Active University Population: A Within-Campus Cross-Sectional Study at a Major Educational InstitutionMarcelo Hernández-Mora, MD0René Arredondo-Hernández, PhD1Carmen A. Castañeda-Camacho, MD2Pamela X. Cervantes-Gutierrez, MD3Gonzalo Castillo-Rojas, PhD4Samuel Ponce de León, MD5Yolanda López-Vidal, PhD6MD, Center for SARS-CoV-2 Diagnosis for the University Community, National Autonomous University of Mexico, Mexico City, MexicoMicrobiome Laboratory, Research Division, National Autonomous University of Mexico, Mexico City, MexicoMD, Center for SARS-CoV-2 Diagnosis for the University Community, National Autonomous University of Mexico, Mexico City, Mexico; Microbiome Laboratory, Research Division, National Autonomous University of Mexico, Mexico City, MexicoMD, Center for SARS-CoV-2 Diagnosis for the University Community, National Autonomous University of Mexico, Mexico City, MexicoMicrobial Molecular Immunology Program, Department of Microbiology and Parasitology, National Autonomous University of Mexico, Mexico City, MexicoMicrobiome Laboratory, Research Division, National Autonomous University of Mexico, Mexico City, Mexico; University Research Programme on Emerging and Epidemiological Risks (PUIREE), National Autonomous University of Mexico, Mexico City, MexicoMD, Center for SARS-CoV-2 Diagnosis for the University Community, National Autonomous University of Mexico, Mexico City, Mexico; Correspondence: Address to Yolanda López-Vidal, PhD, Microbial Molecular Immunology Program, Department of Microbiology and Parasitology, National Autonomous University of Mexico, UNAM, 3000 University Av., H Building, 4th Floor, Coyacan, Mexico City, Mexico, 04510.Objective: To evaluate the associations among post-coronavirus disease 2019 (COVID-19) prevalence; risk factors and comorbidities have not been firmly established within a university outpatient population. Patients and Methods: Records from 881 COVID-19 outpatient patients (504 females [57.9%] and 366 males [42.07%]), most of whom were between 30 and 40 years of age (mean=37.3 years old; 95% CI, 36.5-38.2), with initial infection data from February 2020 to August 2022 were reviewed once, whereas the survey took place during 2 different moments during the pandemic. The first period (April 20, 2021, to June 21, 2021) yielded 279 responses, whereas in the second period (June 23, 2021, to October 4, 2021), 602 responses were recorded. The instrument used contained 20 questions across 3 main domains: general information, data related to infection and adverse effects, and service satisfaction experience. Results: All the patients were positive for immunoglobulin G antibodies against nucleocapsid by the third week. Post-COVID-19 symptoms arose at least 2 weeks after recovery from the initial illness; 654 individuals reported at least one symptom after the acute COVID-19 period, for a post-COVID-19 prevalence of 74.96%. The most frequent symptoms were fatigue (84%), headache (71%), and difficulty concentrating (71%). More than 60% of participants reported at least one comorbidity, among which the most common ones were obesity (35.9%), smoking (17.5%), and hypertension (12.2%). Conclusion: In this study, we assessed post-COVID-19 prevalence among outpatients and found that comorbidities were strongly related to consequences impacting quality of life and mental health burden.http://www.sciencedirect.com/science/article/pii/S2542454824000651 |
| spellingShingle | Marcelo Hernández-Mora, MD René Arredondo-Hernández, PhD Carmen A. Castañeda-Camacho, MD Pamela X. Cervantes-Gutierrez, MD Gonzalo Castillo-Rojas, PhD Samuel Ponce de León, MD Yolanda López-Vidal, PhD Post-Coronavirus Disease 2019 Effects in an Active University Population: A Within-Campus Cross-Sectional Study at a Major Educational Institution Mayo Clinic Proceedings: Innovations, Quality & Outcomes |
| title | Post-Coronavirus Disease 2019 Effects in an Active University Population: A Within-Campus Cross-Sectional Study at a Major Educational Institution |
| title_full | Post-Coronavirus Disease 2019 Effects in an Active University Population: A Within-Campus Cross-Sectional Study at a Major Educational Institution |
| title_fullStr | Post-Coronavirus Disease 2019 Effects in an Active University Population: A Within-Campus Cross-Sectional Study at a Major Educational Institution |
| title_full_unstemmed | Post-Coronavirus Disease 2019 Effects in an Active University Population: A Within-Campus Cross-Sectional Study at a Major Educational Institution |
| title_short | Post-Coronavirus Disease 2019 Effects in an Active University Population: A Within-Campus Cross-Sectional Study at a Major Educational Institution |
| title_sort | post coronavirus disease 2019 effects in an active university population a within campus cross sectional study at a major educational institution |
| url | http://www.sciencedirect.com/science/article/pii/S2542454824000651 |
| work_keys_str_mv | AT marcelohernandezmoramd postcoronavirusdisease2019effectsinanactiveuniversitypopulationawithincampuscrosssectionalstudyatamajoreducationalinstitution AT renearredondohernandezphd postcoronavirusdisease2019effectsinanactiveuniversitypopulationawithincampuscrosssectionalstudyatamajoreducationalinstitution AT carmenacastanedacamachomd postcoronavirusdisease2019effectsinanactiveuniversitypopulationawithincampuscrosssectionalstudyatamajoreducationalinstitution AT pamelaxcervantesgutierrezmd postcoronavirusdisease2019effectsinanactiveuniversitypopulationawithincampuscrosssectionalstudyatamajoreducationalinstitution AT gonzalocastillorojasphd postcoronavirusdisease2019effectsinanactiveuniversitypopulationawithincampuscrosssectionalstudyatamajoreducationalinstitution AT samuelponcedeleonmd postcoronavirusdisease2019effectsinanactiveuniversitypopulationawithincampuscrosssectionalstudyatamajoreducationalinstitution AT yolandalopezvidalphd postcoronavirusdisease2019effectsinanactiveuniversitypopulationawithincampuscrosssectionalstudyatamajoreducationalinstitution |